[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=ae66853d0f37fdc52e4d43205c791a1c846974f590c2e7d78e7da31a042d1eb9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740069900,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 132840440,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=ae66853d0f37fdc52e4d43205c791a1c846974f590c2e7d78e7da31a042d1eb9"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit",
    "summary": "LOS ANGELES, Feb. 20, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Regeneron...",
    "url": "https://finnhub.io/api/news?id=c1c0e7594a50d6e0ced40597aa3bc093c614a4c0f21b1a7cc325e87bb50cbb6b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740052868,
      "headline": "Regeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit",
      "id": 132809023,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "LOS ANGELES, Feb. 20, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Regeneron...",
      "url": "https://finnhub.io/api/news?id=c1c0e7594a50d6e0ced40597aa3bc093c614a4c0f21b1a7cc325e87bb50cbb6b"
    }
  },
  {
    "ts": null,
    "headline": "Faruqi & Faruqi Reminds Regeneron Pharmaceutials Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN",
    "summary": "Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Regeneron To Contact Him Directly To Discuss Their OptionsIf you...",
    "url": "https://finnhub.io/api/news?id=f329b6bb65c0ac25188cc05fcf559c1b337c08e9346fff9cf42c8c58030c2ffe",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740051546,
      "headline": "Faruqi & Faruqi Reminds Regeneron Pharmaceutials Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN",
      "id": 132807576,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Regeneron To Contact Him Directly To Discuss Their OptionsIf you...",
      "url": "https://finnhub.io/api/news?id=f329b6bb65c0ac25188cc05fcf559c1b337c08e9346fff9cf42c8c58030c2ffe"
    }
  },
  {
    "ts": null,
    "headline": "Allspring Disciplined U.S. Core Fund Q4 2024 Commentary",
    "summary": "The Allspring Disciplined U.S. Core Fund returned 4.18% for the quarter. The benchmark S&P 500 Index returned 2.41%. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=927c4aff26a54e36fea7c6399f31ae9ed3db78418f1545245045452361898007",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740045900,
      "headline": "Allspring Disciplined U.S. Core Fund Q4 2024 Commentary",
      "id": 132803150,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1250588879/image_1250588879.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "The Allspring Disciplined U.S. Core Fund returned 4.18% for the quarter. The benchmark S&P 500 Index returned 2.41%. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=927c4aff26a54e36fea7c6399f31ae9ed3db78418f1545245045452361898007"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - REGN",
    "summary": "NEW YORK, Feb. 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. . ...",
    "url": "https://finnhub.io/api/news?id=c8492229c1e6c88631d063069b448946947120e2c8e4f2c016053927090c5ce7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740030382,
      "headline": "Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - REGN",
      "id": 132794851,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, Feb. 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. . ...",
      "url": "https://finnhub.io/api/news?id=c8492229c1e6c88631d063069b448946947120e2c8e4f2c016053927090c5ce7"
    }
  }
]